[The first Tunisian cardiovascular diseases register: processes and results]

H Ben Romdhane1, S Bougatef, H Skhiri

  • 1Laboratoire de Recherche en Epidémiologie et Prévention des Maladies Cardiovasculaires en Tunisie, Institut National de Santé Publique, Le Diplomate (10e étage), 5-7, rue Khartoum, Belvédère, 1002 Tunis, Tunisie. habiba.benromd-hane@rns.tn

Revue D'Epidemiologie Et De Sante Publique
|March 3, 2005
PubMed

Insights

Cardiovascular disease (CVD) incidence data is now available in Tunisia. This study highlights challenges in data collection for coronary heart disease surveillance in developing nations.

Area of Science:

  • Epidemiology
  • Public Health
  • Cardiology

Context:

  • Cardiovascular diseases (CVD) are the leading cause of death in Tunisia, accounting for 30% of all deaths.
  • Risk factor levels for CVD are increasing in the Tunisian population.
  • Implementing a CVD morbidity register was identified as a public health priority.

Purpose:

  • To establish the first CVD morbidity register in Tunisia.
  • To record and analyze coronary heart events in adults aged 25 and above.
  • To assess the incidence and case fatality of myocardial infarction.

Summary:

  • A CVD morbidity register was implemented in 2001 across three Tunisian regions (Tunis, Ariana, Ben Arous), covering approximately 2 million inhabitants.
  • In 2001, 942 myocardial infarction events were recorded. Age-standardized incidence rates in men varied from 161.9 to 170.5 per 100,000, and in women from 43.4 to 61.1 per 100,000.
  • Challenges included medical cause of death registration and data coding, despite using MONICA criteria and WHO-designed death certificates.

Impact:

  • This initiative provides crucial data on coronary heart disease incidence and fatality in Tunisia.
  • The study underscores practical difficulties in disease surveillance in developing countries.
  • Recommendations include improving data quality and integrating the register into the local health system.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...